Literature DB >> 22197534

Clinical outcomes in patients with prolonged intensive care unit length of stay after cardiac surgical procedures.

Ansar Hassan1, Curtis Anderson, Alan Kypson, Linda Kindell, T Bruce Ferguson, W Randolph Chitwood, Evelio Rodriguez.   

Abstract

BACKGROUND: Advances in critical care medicine have allowed for improved care of patients requiring prolonged intensive care unit length of stay (prICULOS) after cardiac operations, yet little is known regarding their eventual outcomes. The purpose of this study was to examine short- and long-term outcomes in patients undergoing cardiac operations with prICULOS.
METHODS: All cases of coronary artery bypass grafting (CABG), aortic valve, mitral valve, and combined CABG/valve surgical procedures performed at a single institution from July 2002 to July 2007 were identified. All-cause mortality in patients discharged alive from the hospital was determined until December 2007 through linkage with the Social Security Death Index. Patients who experienced intraoperative death or those with missing or invalid social security numbers were excluded. The definition of prICULOS was total ICULOS greater than 7 days.
RESULTS: A total of 3,478 patients met inclusion criteria. One hundred thirty-seven of three thousand four hundred seventy-eight patients (3.9%) experienced prICULOS. These patients were more likely to be older than 70 years (55.5% versus 30.5%; p<0.0001) and to have had recent myocardial infarction (28.5% versus 20.1%; p=0.02), previous cardiac operation (18.3% versus 6.9%; p<0.0001), and emergent status (9.5% versus 1.6%; p<0.0001). They experienced greater in-hospital mortality (37.2% versus 1.7%; p<0.0001) and those who were discharged alive had worse long-term survival (log-rank, p<0.0001). After risk adjustment, prICULOS emerged as a significant predictor of in-hospital death (odds ratio [OR] 20.9; 95% confidence interval [CI], 12.9-33.7) and decreased long-term survival (hazard ratio [HR] 2.9; 95% CI, 2.0-4.3).
CONCLUSIONS: Patients with prICULOS after cardiac operations have worse overall outcomes. These data may be used to inform these patients and their families of realistic expectations regarding their clinical course.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197534     DOI: 10.1016/j.athoracsur.2011.10.024

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Functional status and survival after prolonged intensive care unit stay following cardiac surgery.

Authors:  Gopal Soppa; Claudia Woodford; Martin Yates; Riyan Shetty; Matthew Moore; Oswaldo Valencia; Nick Fletcher; Marjan Jahangiri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-12

2.  Inclusion of 'ICU-Day' in a Logistic Scoring System Improves Mortality Prediction in Cardiac Surgery.

Authors:  Fabian Doerr; Matthias B Heldwein; Ole Bayer; Anton Sabashnikov; Alexander Weymann; Pascal M Dohmen; Thorsten Wahlers; Khosro Hekmat
Journal:  Med Sci Monit Basic Res       Date:  2015-07-03

Review 3.  How does the implementation of a patient pathway-based intervention in the acute care of blunt thoracic injury impact on patient outcomes? A systematic review of the literature.

Authors:  Edward Baker; Alison Woolley; Andreas Xyrichis; Christine Norton; Philip Hopkins; Geraldine Lee
Journal:  Injury       Date:  2020-06-04       Impact factor: 2.586

4.  Low vitamin D concentration is not associated with increased mortality and morbidity after cardiac surgery.

Authors:  Alparslan Turan; Martin Grady; Jing You; Edward J Mascha; Worasak Keeyapaj; Ryu Komatsu; C Allen Bashour; Daniel I Sessler; Leif Saager; Andrea Kurz
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

5.  Post-intubation tracheal stenosis after management of complicated aortic dissection: a case series.

Authors:  Jia Liu; Chun-Peng Zhang; Ye Li; Su Dong
Journal:  J Cardiothorac Surg       Date:  2015-11-04       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.